Background and Aim. Amniotic membrane-derived mesenchymal stem cells (hAM-dMSCs) are a potential source of mesenchymal stem cells which could be used to repair skin damage. The use of mesenchymal stem cells to repair skin damage requires safe, effective and biocompatible agents to evaluate the effectiveness of the result. Quantum dots (QDs) composed of CdSe/ZnS are semiconductor nanocrystals with broad excitation and narrow emission spectra, which have been considered as a new chemical and fluorescent substance for non-invasively labeling different cells in vitro and in vivo. This study investigated the cytotoxic effects of QDs on hAM-dMSCs at different times following labeling. Methods. Using 0.75, 1.5 and 3.0 μL between quantum dots, labeled human amniotic mesenchymal stem cells were collected on days 1, 2 and 4 and observed morphological changes, performed an MTT cell growth assay and flow cytometry for mesenchymal stem cells molecular markers. Results. Quantum dot concentration 0.75 μg/mL labeled under a fluorescence microscope, cell morphology was observed, The MTT assay showed cells in the proliferative phase. Flow cytometry expression CD29, CD31, CD34, CD44, CD90, CD105 and CD106. Conclusions. Within a certain range of concentrations between quantum dots labeled human amniotic mesenchymal stem cells has good biocompatibility.
INTRODUCTION
The skin undergoes a cycle of growth and degeneration to ensure the maintenance and homeostasis of adult skin. Stem cells residing in the skin participate in this cycle, but they also play an important role in repair of the epidermis after injury. Mesenchymal stem cells have been isolated from different tissues and have the ability to differentiate into epidermal-like cells 1, 2 . Amniotic membrane-derived mesenchymal stem cells (hAM-dMSCs), with low immunogenicity and anti-inflammatory properties, have attracted attention as a novel source of stem cells, providing a potential source of mesenchymal stem cells to repair skin damage. Such repair requires the use of safe, effective and biocompatible agents to evaluate the effectiveness of the result. Different cell labeling reagents have been used, including biological dyes, radioactive reagents, and fluorescent protein antibodies among others 3, 4 . Each of these labeling methods has its own disadvantages, such as low intensity, short labeling time and complicated procedures. Quantum Dots (QDs) are semiconductor nanocrystalloid particles which have a nano-scale character combined with a bright and stable emission spectrum, and can be used to label cells from different sources [5] [6] [7] [8] . We recently received nanoparticle quantum dots from Lanzhou University that are composed of CdSe/ZnS, enabling their detection with a fluorescence microscope 9, 10 . Nanotoxicology aims to evaluate the relationship between physical and chemical properties and toxic biological responses. Few data are available on the toxicity of QDs in human amniotic membrane-derived mesenchymal stem cells (hAM-dMSCs). We used biological approaches to evaluate the effects of QDs on hAM-dMSCs, including cell growth, cell viability and accumulation of QDs. The study investigated the effect of the cytotoxicity of QDs on hAM-dMSCs over different labeling durations. hAMdMSCs could be efficiently labeled at safe concentrations of QDs (≤ 0.75 μg/mL) without significantly affecting their viability (> 80% by MTT assay with maintenance of normal morphology) or expression of specific surface antigens (CD29, CD44, CD90, CD105 analyzed by flow cytometry) from 1 to 4 d.
MATERIALS AND METHODS

Cell preparation
This study was approved by the medical ethics board of the First Affiliated Hospital of Henan University of Science and Technology. Samples of amniotic membranes were obtained from full-term pregnant women during elective cesarean sections; each subject was fully informed of the procedure and consent was provided by each participant. Amniotic membranes were prepared according to the method previously described by Yang et al.
11
.
Quantum dot (QD) labeling
Quantum dots (QDs, Lanzhou University, PR China) were used in this study. Aliquots of 0.75, 1.5 and 3.0 μL were removed from 1 mL of cytokine growth medium (CGM) which contains Dulbecco's modified eagle's medium-Low glucose (DMEM-LG; Gibco BRL, USA) and 10 ng/mL of basic fibroblast growth factor (bFGF; Sigma, USA) , the corresponding volume of QDs suspension was added (final concentrations equivalent to 0.75, 1.5 and 3.0 μL QDs per mL) to establish different concentrations of QDs. hAM-dMSCs cultured in CGM containing different concentrations of QDs were harvested at 1, 2 and 4 d, and then divided into three parts: the first part was used to analyze the morphological and growth characteristics of the hAM-dMSCs; the second part was used for the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay to assess the cytotoxicity of the QD suspension; the third part was used to detect the expression of surface antigens by hAM-dMSCs.
Statistical analysis
Data are expressed as the mean ± standard error (SE), and one-way analysis of variance was used to compare the survival rates of hAM-dMSCs in the different groups. Differences were considered to be statistically significant when P < 0.05.
RESULTS
QD for imaging by fluorescence microscopy
QDs emit a red color upon excitation with a single wavelength of light at 570 nm using a fluorescence microscope (DMIL; Leica, Germany). (Fig. 1 A) . At the same wavelength, hAM-dMSCs stained with QDs (1.5 μg/ mL) when viewed under a fluorescence microscope at 1 d ( Fig. 1 B, C) .
Growth characterization of hAM-dMSCs in primary culture
hAM-dMSCs were prepared according to the method previously described by Yang et al. 11 , the cells retained their polygonal fibroblast-like morphological characteristics ( Fig. 2 ) and maintained a strong mitotic competency to passage 10.
Surface antigens of hAM-dMSCs in primary culture
hAM-dMSCs cultured in CGM expressed CD29, CD31, CD34, CD44, CD90, CD105 and CD106 (Fig. 3) .
Effects of QD-labeling on hAM-dMSCs
Under different QD concentrations, QDs could be detected on the plasma membrance of hAM-dMSCs following different QD-labeling times. Inside cells, QDs still retained their spectral profile, while hAM-dMSCs was the excitation wavelength 570 nm under a fluorescence microscope following excitation ( Fig. 1 B, C) . Following 1 d of culture, the viability of cells labeled with QDs at various concentrations was evaluated. Cells labeled with QDs at concentrations ≤ 1.5 μg/mL were > 80% viable; at 2 d, samples labeled with QDs at concentrations ≤ 0.75 μg/mL were > 80% viable; at 4 d, samples labeled with QDs at concentrations ≤ 0.75 μg/mL were > 80% viable. Control samples that were not labeled with QDs were > 80% viable at 1, 2 and 4 d (Fig. 4) . The polygonal fibroblast-like mor- phological characteristics and surface antigens of hAMdMSCs were not significantly different between samples labeled with various concentrations of QDs and unlabeled controls, all of which were > 80% viable (Fig. 5, 6 ).
DISCUSSION
Stem cells play an important role in the regeneration of damaged tissues or the recovery of functional deficits in human disease. Mesenchymal stem cells (MSCs) have been found in multiple tissues, including bone marrow, adipose tissue, the umbilical cord and Wharton's jelly, amongst others 12, 13 . To date, many studies both in vitro and in vivo have proved that MSCs can differentiate into epidermal-like cells or secrete specific epidermal cell proteins in specific chemical and cytokine microenvironments [14] [15] [16] [17] . MSCs transplanted into animal models of damaged skin can survive, migrate, proliferate and differentiate, and have been shown to repair skin damage and improve the recovery of functional skin [18] [19] [20] [21] [22] . The amniotic membrane displays many advantageous characteristics; it is easy to obtain at low cost, has little antigenic and anti-bacterial activity, and can be stored. Interestingly, hAM-dMSCs can be obtained from the amniotic membrane of discarded placental tissue, which provides a novel and attractive stem cell source and would avoid any ethical controversy. Many studies have demonstrated that special surface antigens, such as CD29, CD44, CD90 and CD105, can be detected on MSCs from different tissues [23] [24] [25] . In our study, MSCs isolated from human amniotic membrane showed high expression levels of CD29, CD44, CD90 and CD105, and were negative for CD31, CD34, CD45 and CD106; additionally, the morphological and growth characteristics of hAM-dMSCs were similar to MSCs from other tissues. If hAM-dMSCs are to be used to repair damaged skin, it is important to identify a highly effective method of labeling hAM-dMSCs before transplantation.
In our study we aimed to solve this problem, but monitoring transplanted cells in vivo is a challenge for the assessment of successful cell therapy. The identification of a noninvasive and nontoxic method is important for cell tracking in vivo. Recently, the use of fluorescent agents has begun to play an important role in the study of cellular structure, labeling of cellular molecules, and monitoring of different cells both in vivo and in vitro. However, traditional fluorescent agents have certain disadvantages, including broad emission spectra, limited brightness and low photostability, that limit long-term observation. Quantum dots (QDs) -small (1-10 nm) semiconductor nanocrystalloid particles with high durability and unique optical properties -are one of the most exciting materials in nanobiotechnology 26, 27 . Compared with traditional fluorescent agents, quantum dots have nano-scale characteristics and bright and stable emission spectra. QDs have been used for labeling living cells and tissues. Endocytosis/phagocytosis or uptake by specific receptors or channels are processes used by many cell types to internalize larger proteins or nutrients. Recently, reports have indicated that QDs can be internalized into living cells through such endocytotic mechanisms. Once inside cells, QDs still retain their spectral profile. In our study, Fig. 3 . Surface antigens of hAM-dMSCs in primary culture. In flow cytometry, hAM-dMSCs at passage 3 were positive for CD29 (A1, A2), CD44 (B1, B2), CD90 (C1, C2) and CD105 (D1, D2), and negative for CD31(E1, E2), CD34 (F1, F2), CD45 (G1, G2) and CD106 (H1, H2). Mouse IgG conjugated with FITC or PE served as the negative controls (I1, I2) and (J1, J2). Data are shown as the mean ± standard error (S.E.) (n=8). 100% of hAM-dMSCs were consistently loaded with different amount of QDs at different times. If they are to be used in vivo, these particles must be characterized to assess their biocompatibility. This is in comparison with other nanoparticles, such as iron nanoparticles, which have proven to be biocompatible. QDs as new materials have not been completely characterized for their toxicity in hAM-dMSCs.
Materials which affect the cell and allow viability of more than 80% are recognized as biocompatible 28 . In our experiments on QD-labeled hAM-dMSCs, results of the MTT assay revealed no significant differences between cells labeled with QDs at concentrations of 0.75 μg/mL and 1.5 μg/mL at 1 d, with cell viability of all samples of > 80%. After 1 d, the viability of QD-labeled hAMdMSCs was > 80% when the initial QD concentration was 0.75 μg/mL. High concentrations of QDs exhibited acute and chronic cytotoxic effects on hAM-dMSCs; the cell viability of samples was < 80% when the initial QD concentrations were 3.0 μg/mL at 1d and 1.5 μg/mL at 2d. Our study revealed that concentrations ≤ 0.75 μg/mL were safe for QD labeling of hAM-dMSCs. hAM-dMSCs labeled with safe concentrations of QDs and harvested at 1, 2 and 4 d expressed CD29, CD44, CD90, CD105, CD31, CD34, CD45 and CD106, which were similar to unlabeled samples in primary culture (3 passages). 6 . Images of QD-labeled hAM-dMSCs. The images of QDs-labeled hAM-dMSCs before and after fluorescence microscope. Images of 0.75 μg/mL QD-labeled hAM-dMSCs which excite red color and keep normal morphological shape at 2d (A1 before fluorescence microscope, A2 after fluorescence microscope) and 4d (B1 before fluorescence microscope, B2 after fluorescence microscope). Images of 3.0 μg/mL QD-labeled hAM-dMSCs which were taken off the surface of the cell culture dish and shaped spherocyte at 1d (A3 before fluorescence microscope, B3 after fluorescence microscope ). Images of 1.5 μg/mLQD-labeled hAMdMSCs which excite red color and lost fibroblast-like morphological shape at 2d (A4 before fluorescence microscope, B4 after fluorescence microscope ) Scale bar = 25 μm (n=8).
CONCLUSION
We isolated hAM-dMSCs with high expression levels of CD29, CD44, CD90 and CD105. Safe concentrations of QDs for labeling of hAM-dMSCs, resulting in cell viabilities > 80% were ≤ 0.75 μg/mL from 1 to 4 d. These concentrations do not alter the morphological characteristics of hAM-dMSCs or their expression of specific surface antigens such as CD29, CD44, CD90 and CD105.
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